Prevalence of COVID-19 among emergency department staff
Study of Prevalence of the Covid-19 Among the Staff of the Emergency Department
This study looks at how many emergency department staff members were exposed to COVID-19 during the pandemic to better understand their risk.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 320 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Trial ID | NCT06200610 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the seroprevalence of SARS-CoV-2 among healthcare personnel working in the emergency services of Strasbourg University Hospitals and Besançon University Hospital. It focuses on adult staff members who were active during the COVID-19 pandemic from March to May 2020 and who have consented to the use of their biological resources for research. The study will analyze serological data to understand the extent of COVID-19 exposure among these frontline workers.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who worked in the emergency departments of the participating hospitals during the specified pandemic period.
Not a fit: Patients who did not work in the emergency departments during the pandemic or who have opted out of participating will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the risk of COVID-19 exposure among emergency department staff, informing better protective measures.
How similar studies have performed: Other studies have successfully assessed seroprevalence among healthcare workers during the pandemic, indicating that this approach is validated and relevant.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult (≥18 years old) * Part of the emergency staff of the HUS or Besançon University Hospital having worked during the period of the covid-19 pandemic, from March 1, 2020 to May 31, 2020. * Having carried out serology within the framework of the recommendations of the High Authority of Health of May 2, 2020 on the screening of caregivers * Having given consent for its biological resources to be reused for research purposes Exclusion Criteria: * Subject having expressed opposition to participating in the study
Where this trial is running
Strasbourg
- Service d'Accueil des Urgences - CHU de Strasbourg - France — Strasbourg, France (Recruiting)
Study contacts
- Study coordinator: Sabrina Garnier Kepka, MD
- Email: Sabrina.GARNIER-KEPKA@chru-strasbourg.fr
- Phone: 33 3 69 55 13 35
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.